Tumor necrosis factor-α: Molecular-biological aspects minireview

Neoplasma

Volumn 46, Issue 5, 1999, Pages 257-266

  Szatmary Z ^a  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

Author keywords

Pentoxifylline; RT PCR; TNF assaying; TNF expression; TNF signal transduction; Tumor necrosis factor

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PENTOXIFYLLINE; PHOSPHOLIPASE; PHOSPHOPROTEIN PHOSPHATASE; PROTEINASE; SPHINGOMYELIN PHOSPHODIESTERASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; ENZYME ACTIVATION; HOST RESISTANCE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR IMMUNOLOGY;

EID: 0345634202     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. ABATE, C., PATEL, L., RAUSCHER, F.J. 3RD, CURRAN, T.: Redox regulation of fos and jun DNA-binding activity in vitro. Science, 249, 1990, 1157-1161.
2. AHMAD, M., THEOFANIDIS, P., MEDFORD, R.M.: Role of activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-alpha. J. Biol. Chem., 273, 1998, 4616-4621.
3. ALBERTS, A.S., DENG, T., LIN, A., MEINKOTH, J.L., SCHONTAL, A., MUMBY, M.C., KARIN, M., FERAMISCO J.R.: Protein phosphatase 2A potentiates activity of promoters containig AP-1-binding elements. Mol. Cell. Biol., 13, 1993, 2104-2012.
4. ANSORGE, W.: Fast and sensitive detection of protein and DNA bands by treatment with potassium permanganate. J. Biochem. Biophys. Methods, 11, 1985, 13-20.
5. ASANO, H., KOBAYASHI, T., UCHIDA, K., HAYASHI, S., YOKOYAMA, I., INOKO, H., TAKAGI, H.: Significance of tumor necrosis factor microsatellite polymorphism in renal transplantation. Tissue Antigens, 50, 1997, 484-488.
6. AUWERX, J., SASSONE-CORSI, P.: IP-1: A dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylation. Cell, 64, 1991, 983-993.
7. BALKWILL, F.R.: Cytokines. New York, Oxford University Press 1991.
8. BENVENISTE, O., MARTIN, M., VILLINGER, F., DORMONT, D.: Techniques for quantification of cytokine mRNA. Cytokines Cell. Mol. Ther., 4, 1998, 207-214.
9. BOYLE, W.J., SMEAL, T., DEFIZE, L.H., ANGEL, P., WOODGETT, J.R., KARIN, M., HUNTER, T.: Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell, 64, 1991, 573-584.
10. BRADHAM, C.A., STACHLEWITZ, R.F., GAO, W., QIAN, T., JAYADEV, S., JENKINS, G., HANNUN, Y., LEMASTERS, J.J., THURMAN, R.G., BRENNER, D.A.: Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases. Hepatology, 25, 1997, 1128-1135.
11. BROSTJAN, C., ANRATHER, J., CSIZMADIA, V., NATARAJAN, G., WINKLER, H.: Glucocorticoids inhibit E-selectin expression by targeting NF-kappaB and not ATF/c-jun. J. Immunol., 158, 1997, 3836-3844.
12. CHINNAIYAN, A.M., O'ROURKE, K., TEWARI, M., DIXIT, V. M.: FADD, a novel death domain - containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81, 1995, 505-512.
13. COHEN, G.M.: Caspases: The executors of apoptosis. Biochem. J., 326, 1997, 1-16.
14. CONNELLY, M.A., MARCU, K.B.: CHUK, a new member of the helix-loop-helix and leucine zipper families of interacting proteins, contains a serine-threonine kinase domain. Cell. Mol. Biol. Res., 41, 1995, 537-549.
15. DECKERT-SCHLUTER, M., BLUETHMANN, H., RANG, A., HOF, H., SCHLUTER, D.: Crucial role of TNF-receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis. J. Immunol., 160, 1998, 3427-3436.
16. DEVITT, A. MOFFATT, O.D., RAYKUNDALIA, C., CAPRA, J.D., SIMMONS, D.L., GREGORY, C.D.: Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature, 392, 1998, 505-509.
17. DEZUBE, B.J., LEDERMAN, M.M.: Pentoxifylline for the treatment of HIV infection and its complications. J. Cardiovasc. Pharmacol., 25, 1995, S139-S142.
18. DUAN, H., DIXIT, V.M.: RAIDD is a new "death" adaptor molecule. Nature, 385, 1997, 86-89.
19. DURIEZ, P.J., SHAH, G.M.: Cleavage of poly(ADP-ribose) polymerase: A sensitive parameter to study cell death. Biochem. Cell. Biol., 75, 1997, 337-349.
20. ELKON, K.B., LIU, C.C., GALL, J.G., TREVEJO, J., MARINO, M.W., ABRAHAMSEN, K.A., SONG, X., ZHOU, J. L., OLD, L.J., CRYSTAL, R.G., FALCK-PEDERSEN, E.: Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors. Proc. Natl. Acad. Sci. USA, 94, 1997, 9814-9819.
21. FIERS, W.: Tumor necrosis factor: Characterization at the molecular, cellular and in vivo level. FEBS Lett., 285, 1991, 199-212.
22. FRANKLIN, C.C., KRAFT, A.S.: Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-jun transcriptional activity in U937 human leukemic cells. Oncogene, 11, 1995, 2365-2374.
23. GALANOS, C., FREUDENBERG, M.A.: Mechanisms of endotoxin shock and endotoxin hypersensitivity. Immunobiology, 187, 1993, 346-356.
24. GU, C., CASTELLINO, A., CHAN, J.Y., CHAO, M.V.: BRE: A modulator of TNF-alpha action. FASEB J., 12, 1998, 1101-1108.
25. GUPTA, S., CAMPBELL, D., DERIJARD, B., DAVIS, R.J.: Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science, 267, 1995, 389-393.
26. HEPBURN, A., BOEYNAEMS, J.M., FIERS, W., DUMONT, J.E.: Modulation of tumor necrosis factor-alpha cytotoxicity in L929 cells by bacterial toxins, hydrocortisone and inhibitors of arachidonic acid metabolism. Biochem. Biophys. Res. Commun., 149, 1987, 815-822.
27. HOHMANN, H.P., REMY, R., POSCHL, B., VAN LOON, A.P.G.M.: Tumor necrosis factor-alpha and -beta bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-kappaB at low receptor occupancy and within minutes after receptor binding. J. Biol. Chem., 265, 1990, 15 183-15 188.
28. Hsu, H., XIONG, J., GOEDDEL, D.V: The TNF receptor 1 -associated protein TRADD signals cell death and NF-κB activation. Cell, 81, 1995, 495-504.
29. ISRAEL, A., LE BAIL, O., HATAT, D., PIETTE, J., KIERAN, M., LOGEAT, F., WALLACH, D., FELLOUS, M., KOURILSKY, P.: TNF stimulates expression of mouse MHC class I genes by inducing an NF kappaB-like enhancer binding activity which displaces constitutive factors. EMBO J., 8, 1989, 3793-3800.
30. JABBAR, S.A., HOFFBRAND, A.V., WICKREMASINGHE, R.G.: Defects in signal transduction pathways in chronic B lymphocytic leukemia cells. Leuk. Lymphoma, 18, 1995, 163-170.
31. JANS, D.A.: The regulation of protein transport to the nucleus by phosphorylation. Biochem. J., 311, 1995, 705-716.
32. JENISON, R.D., GILL, S.C., PARDI, A., POLISKY, B.: High-resolution molecular discrimination by RNA. Science, 263, 1994, 1425-1429.
33. JEREMIAS, I., KUPATT, C., BAUMANN, B., HERR, I., WIRTH, T., DEBATIN, K.M.: Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells. Blood, 91, 1998, 4624-4631.
34. JERNE, N.K., HENRY, C., NORDIN, A.A., FUJI, H., KOROS, A.M.C., LEFTKOVITS, I.: Plaque forming cells: Methodology and theory. Transplant. Rev., 180, 1974, 130-191.
35. KALLUNKI, T., SU, B., TSIGELNY, I., SLUSS, H.K., DERIJARD, B., MOORE, G., DAVIS, R., KARIN, M.: JNK2 contains a specificity determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev., 8, 1994, 2996-3007.
36. KIRK, A.D., BOLLINGER, R.R., FINN, O.J.: Rapid, comprehensive analysis of human cytokine mRNA and its application to the study of acute allograft rejection. Hum. Immunol., 43, 1995, 113-128.
37. KOSEKI, T., INOHARA, N., CHEN, S., NUNEZ, G.: ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc. Natl. Acad. Sci. USA, 95, 1998, 5156-5160.
38. KYRIAKIS, J.M., BANERJEE, P., NIKOLAKAKI, E., DAI, T., RUBIE, E.A., AHMAD, M.F., AVRUCH, J.: The stress-activated protein subfamily of c-Jun kinases. Nature, 369, 1994, 156-160.
39. LI, X.Y., GREEN, M.R.: Intramolecular inhibition of activating transcription factor-2 function by its DNA-binding domain. Genes Dev., 10, 1996, 517-527.
40. LING, L., CAO, Z., GOEDDEL, D.V: NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176. Proc. Natl. Acad. Sci. USA, 95, 1998, 3792-3797.
41. MANTHEY, C.L., SCHUCHMAN, E.H.: Acid sphingomyelinase-derived ceramide is not required for inflammatory cytokine signalling in murine macrophages. Cytokine, 10, 1998, 654-661.
42. MATTHEWS, N., NEALE, M.L., JACKSON, S.K., STARK, J.M.: Tumor cell killing by tumor necrosis factor: Inhibition by anaerobic conditions, free-radical scavengers and inhibitors of arachidonate metabolism. Immunology, 62, 1987, 153-155.
43. MENCACCI, A., CENCI, E., DEL SERO, G., FEDOSTIANI, C., MOSCI, P., MONTAGNOLI, C., BACCI, A., BISTONI, F., QUESNIAUX, V.F., RYFFEL, B., ROMANI, L.: Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-alpha double-deficient mice infected with Candida albicans. Int. Immunol., 10, 1998, 37-48.
44. MITCHELL, R.L., ZOKAS, L., SCHREIBER, R.D., VERMA, I. M.: Rapid induction of the expression of proto-oncogene fos during human monocylic differentiation. Cell, 40, 1985, 209-217.
45. MORIGUCHI, T., KUROYANAGI, N., YAMAGUCHI, K., GOTOH, Y., IRIE, K., KANO, T., SHIRAKABE, K., MURO, Y., SHIBUYA, H., MATSUMOTO, K., NISHIDA, E., HAGIWARA, M.: A novel kinase cascade mediated by mitogen-activated protein kinase, kinase 6 and MKK3. J. Biol. Chem., 271, 1996, 13 675-13 679.
46. MULLER, J.M., ZIEGLER-HEITBROCK, H.W., BAUERLE, P.A.: Nuclear Factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology, 187, 1993, 233-256.
47. NAKANO, H., SHINDO, M., SAKON, S., NISHINAKA, S., MIHARA, M., YAGITA, H., OKUMURA, K. : Differential regulation of IkappaB kinase alpha and beta by upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK. Proc. Natl. Acad. Sci. USA, 95, 1998, 3537-3542.
48. NEWELL, C.L., DEISSEROTH, A.B., LOPEZ-BERESTEIN, G.: Interaction of nuclear proteins with an AP-1/CRE-like promoter sequence in the human TNF-α gene. J. Leuk. Biol., 56, 1994, 27-35.
49. OBERLEY, L.W., BUETTNER, G.R.: Role of superoxide dismutase in cancer. Cancer Res., 39, 1979, 1141-1149.
50. OSBORN, L., KUNKEL, S., NABEL, G.J.: Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc. Natl. Acad. Sci. USA, 86, 1989, 2336-2340.
51. PAULI, U.: Control of tumor necrosis factor gene expression. Crit. Rev. Eukaryotic Gene Exp., 4, 1994, 323-344.
52. PLATZER, C., MEISEL, C., VOGT, K., PLATZER, M., VOLK, H.D.: Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int. Immunol., 7, 1995, 514-523.
53. POBER, J.S., SLOWIK, M.R., DE LUCA, L.G., RITCHIE, A.J.: Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J. Immunol., 150, 1993, 5114-5123.
54. RAMSHAW, I.A., RAMSAY, A.J., KARUPIAH, G., ROLPH, M.S., MAHALINGAM, S., RUBY, J.C.: Cytokines and immunity to viral infections. Immunol. Rev., 159, 1997, 119-135.
55. REGNIER, C.H., SONG, H.Y., GAO, X., GOEDDEL, D.V., CAO, Z., ROTHE, M.: Identification and characterization of an IkappaB kinase. Cell, 90, 1997, 373-383.
56. REMICK, D.G.: Applied molecular biology of sepsis. J. Crit. Care, 10, 1995, 198-212.
57. RUDLOFF, H.E., SCHMALSTIEG, F.C. JR., MUSHTAHA, A.A., PALKOWETZ, K.H., LIU, S.K., GOLDMAN, A.S.: Tumor necrosis factor-α in human milk. Pediatr. Res., 31, 1992, 29-33.
58. SAKURAI, A., MAEKAWA, T., SUDO, T., ISHII, S., KISHIMOTO, A.: Phosphorylation of cAMP response element-binding protein, CRE-BP1, by cAMP-dependent protein kinase and protein kinase C. Biochem. Biophys. Res. Commun., 181, 1991, 629-635.
59. SAKURAI, H., SHIGEMORI, N., HASEGAWA, K., SUGITA, T.: TGF-beta-activated kinase 1 stimulates NF-kappa B activation by an NF-kappa B-inducing kinase-independent mechanism. Biochem. Biophys. Res. Commun., 243, 1998, 545-549.
60. SEDGWICK, J.D., HOLT, P.G.: Kinetics and distribution of antigen-specific IgE-secreted cells during the primary antibody response in the rat. J. Exp. Med., 157, 1983, 2178-2183.
61. SEN, R., BALTIMORE, D.: Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell, 46, 1986, 705-716.
62. SHIRAKABE, K., YAMAGUCHI, K., SHIBUYA, H., IRIE, K., MATSUDA, S., MORIGUCHI, T., GOTOH, Y., MATSUMOTO, K., NISHIDA, E.: TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-jun N-terminal kinase. J. Biol. Chem., 272, 1997, 8141-8144.
63. SCHIEVELLA, A.R., CHEN, J.H., GRAHAM, J.R., LIN, L.L.: MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase. J. Biol. Chem., 272, 1997, 12 069-12 075.
64. SCHWENGER, P., BELLOSTA, P., VIETOR, I., BASILICO, C., SKOLNIK, E.Y., VILCEK, J.: Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor - induced c-jun N-terminal kinase/stress-activated protein kinase activation. Proc. Natl. Acad. Sci. USA, 94, 1997, 2869-2873.
65. SMEAL, T., BINETRUY, B., MERCOLA, D., GROVER-BARDWICK, A., HEIDECKER, G., RAPP, U.R., KARIN, M.: Oncoprotein-mediated signaling cascade stimulates c-jun activity by phosphorylation of serines 63 and 73. Mol. Cell Biol., 12, 1992, 3507-3513.
66. SPRINGER, T.A.: Adhesion receptors of the immune system. Nature, 346, 1990, 425-34.
67. SRINIVASULA, S.M., AHMAD, M., OTTILIE, S., BULLRICH, F., BANKS, S., WANG, Y., FERNANDES-ALNEMRI, T., CROCE, C.M., LITWACK, G., TOMASELLI, K.J., ARMSTRONG, R.C., ALNEMRI, E.S.: FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J. Biol. Chem., 272, 1997, 18 542-18 545.
68. STANGER, B.Z., LEDER, P., LEE, T.H., KIM, E., SEED, B.: RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell, 81, 1995, 513-523.
69. STRIETER, R.M., KUNKEL, S.L., BONE, R.C.: Role of tumor necrosis factor-α in disease states and inflammation. Crit. Care Med., 21, 1993, S447-S463.
70. SUFFYS, P., BEYAERT, R., VAN ROY, F, FIERS, W.: Reduced tumor necrosis factor-α induced cytotoxicity by inhibitors of the arachidonic acid metabolism. Biochem. Biophys. Res. Commun., 149, 1987, 735-743.
71. SUFFYS, P., BEYAERT, R., DE VALCK, D., VANHAESEBROECK, B., VAN ROY, F., FIERS, W.: Tumor necrosis factor - mediated cytotoxicity is correlated with phospholipase-A2 activity, but not with arachidonic acid release per se. Eur. J. Biochem., 195, 1991, 465-475.
72. VAN HINSBERG, V.W., KOOISTRA, T., VAN DER BERG, E.A., PRINCEN, H.M., FIERS, W., EMEIS, J.J.: Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood, 72, 1988, 1467-1473.
73. VANHAM, G., TOOSI, Z., HIRSCH, C.S., WALLIS, R.S., SCHWANDER, S.K., RICH, E.A., ELLNER, J.J.: Examining a paradox in the pathogenesis of human pulmonary tuberculosis: Immune activation and suppression/anergy. Tuber. Lung Dis., 78, 1997, 145-158.
74. VIETOR, I., OLIVEIRA, I.C., VILCEK, J.: CCAAT box enhancer binding protein α (C/EBP-α) stimulates κB element-mediated transcription in transfected cells. J. Biol. Chem., 271, 1996, 5595-5602.
75. WERSHIL, B.K., FURUTA, G.T., LAVIGNE, J.A., CHOUDHURY, A.R., WANG, Z.S., GALLI, S.J.: Dexamethasone and cyclosporine A suppress mast cell-leukocyte cytokine cascades by multiple mechanisms. Int. Arch. Allergy Immunol., 107, 1995, 323-324.
76. WHITE, D.W., HARTY, J.T.: Perforin-deficient CD8+ T cells provide immunity to Listeria monocytogenes by a mechanism that is independent of CD95 and IFN-gamma but requires TNF-alpha. J. Immunol., 160, 1998, 898-905.
77. WONG, G.H., ELWELL, J.H., OBERLEY, L.W., GOEDDEL, D.V.: Manganous Superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell, 58, 1989, 923-931.
78. YAMAMOTO, S., YAMAMOTO, K., KUROBE, H., YAMASHITA, R., YAMAGUCHI, H., UEDA, N.: Transcriptional regulation of fatty acid cyclooxygenases-1 and -2. Int. J. Tissue React., 20, 1998, 17-22.
79. YOZA, B., LARUE, K., MCCALL, C.: Molecular mechanisms responsible for endotoxin tolerance. Prog. Clin. Biol. Res., 397, 1998, 209-215.
80. ZANDI, E., ROTHWARF, D.M., DELHASE, M., HAYAKAWA, M., KARIN, M.: The IkappaB complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell, 91, 1997, 243-252.